Report Questions Pfizer's Anti-Smoking Drug
Nonprofit researchers called for increased scrutiny of Pfizer Inc.'s Chantix following reports that the smoking-cessation drug had caused more serious injuries than any other drug in the first quarter....To view the full article, register now.
Already a subscriber? Click here to view full article